@chromacodeinc profile picture
ChromaCode, Inc. @chromacodeinc

ChromaCode is a molecular diagnostics company with a bioinformatics focus.

Joined October 2017
  • Tweets 317
  • Following 233
  • Followers 142
144 Photos and videos
Pinned Tweet
ChromaCode, Inc.@chromacodeinc
18 Jan 2024
Attending @PMWCintl? Don’t miss the presentation by our CBO, Padma Sundar, who is speaking about using our #HDPCR assay for high TAM applications which might otherwise require #NGS, as part of the Showcase Track S2: Clinical Dx/Tools Track. pmwcintl.com/speaker/padma-s… #PMWC24
1
2
132
In this story in @Tech_Networks originally by @UCDavis, Innovative blood tests can spot cancer 18 months before CT scans, highlighting the value of technologies such as ChromaCode develops. For more: bit.ly/495d1Pd #HealthTech #HealthInnovation
36
🧬 Genetic testing for cancer risk is becoming more affordable, thanks to firms like ChromaCode. Learn how advancements in genetic screening, as reported by @NPR's Nell Greenfieldboyce, are saving lives. n.pr/45c2v7j #GeneticTesting
1
33
In the continuing series 'Conversations Life Science Leaders Aren't Having,' hear our Chairman & CEO Mark McDonough highlight @ChromaCodeInc’s pivotal role in enhancing investor confidence. #Biotech #Innovation #JPM2024 #Genomics x.com/russopartners/status/1…

Russo Partners@russopartners
14 Feb 2024
Mark McDonough of @chromacodeinc: Driving investor confidence with innovative organ transplant diagnostics in 2024. Their tech aims to revolutionize testing, boosting #BioTech investment through strategic partnerships. #HealthTech #InvestorConfidence
2:11
38
#ICYMI: Mark McDonough of @ChromaCodeInc discusses the game changing HDPCR tech with @MedDevNTech. By bridging the gap in genomics, ChromaCode strives to deliver cost-effective solutions that more quickly deliver results. For more: bit.ly/3IoqkPY #HealthTech #Genomics
0:31
25
🎧 Listen to the @Medtech_Insight podcast featuring @ChromaCodeInc's Mark McDonough, discussing the innovative genomic solutions they're developing to facilitate targeted treatment of cancer. More here: bit.ly/4bZ7ZXj #HealthcareInnovation #Cancer
2
24
First in Human podcast by Vial features Mark McDonough of @ChromaCodeInc on the impact of early detection on disease outcomes. From military to Chairman & CEO, hear how he's leading change in genomics. bit.ly/49SQuWW #Innovation #Genomics
1
19
In this continuing series 'Conversations Life Science Leaders Aren't Having,' hear our Chairman & CEO Mark McDonough on @ChromaCodeInc’s growth discipline in today’s challenging environment. #Biotech #Innovation #JPM2024 #Genomics x.com/russopartners/status/1…

Russo Partners@russopartners
22 Jan 2024
Mark McDonough of @ChromaCode discusses the importance of growth discipline in #BioTech on "Conversations Life Science Leaders Aren't Having" with @jeffdharmon74. Post- #JPM2024, Mark emphasizes innovation and being good stewards of capital. #HealthcareInnovation #Resilience
4:17
25
Did you know our cloud analysis platform recently got an upgrade? ChromaCode Cloud 6.1 represents a significant leap forward in our commitment to enhancing our cutting-edge #genomics solutions. bit.ly/48eMUoS #dPCR #Oncology #Innovation
15
#MeetTheTeam – Brett Brown, our VP of Finance and Administration, has over twenty years of experience in finance, corporate management, and human resources. chromacode.com/leadership-te… #genetics #oncology #leadership #dPCR
16
It was great seeing everyone at @PMWCintl! We had an excellent time speaking with our colleagues in the #precisionmedicine space. Special thanks to everyone who came to our workshop and made it successful! #Oncology #Genomics #dPCR
1
12
Today is #WorldCancerDay, a day to recognize the high toll that cancer takes around the world. Because of a lack of accessibility, many people around the world aren’t able to receive the most effective cancer treatments. worldcancerday.org/ #CloseTheCareGap @worldcancerday
18
#ICYMI – Mark McDonough, ChromaCode’s CEO, was recently featured on @mydocwire, where he spoke about our #HDPCR technology and the need for our #NSCLC assay. docwirenews.com/post/a-rapid… #genetics #oncology #leadership #dPCR
13
Our #HDPCR assay for #NSCLC has faster turn-around times compared to #NGS and more comprehensive results compared to standard #dPCR. Check it out: chromacode.com/oncology/
14
We’re proud to announce the publication of a study in the scientific journal Diagnostics demonstrating that our #HDPCR #NSCLC assay outperforms #NGS in cases where there is low sample input. Learn more: prn.to/48PDBfV #Oncology #Innovation #Publication #Genetics
2
66
Don’t miss TODAY’S presentation by our CBO, Padma Sundar, who is speaking about using our #HDPCR assay for high TAM applications which might otherwise require #NGS, as part of @PMWCintl’s Showcase Track S2: Clinical Dx/Tools Track. pmwcintl.com/speaker/padma-s… #PMWC24 #genomics
22
Our CBO, Padma Sundar, is speaking at @PMWCintl about using our #HDPCR assay as an alternative for high TAM applications for applications which might otherwise require #NGS, as part of the #PMWC24’s Showcase Track S2: Clinical Dx/Tools Track. pmwcintl.com/speaker/padma-s…
17
#MeetTheTeam – Crane Harris, our VP of corporate development, brings extensive experience working for #genomic companies to ChromaCode. He is passionate about developing #collaborations that allow us to further develop our #HDPCR technologies. chromacode.com/leadership-te…
1
1
72
Recently we announced the following changes to our Board of Directors: ➡Mark McDonough, ChromaCode CEO, was appointed Chairman ➡ Former Chair, Carol Gallagher, Pharm.D., retired from the board ➡ Michele Park, Ph.D., was appointed to the board prnewswire.com/news-releases…
4
36
Our CEO, Mark McDonough, engaged in an insightful discussion with Jeff Harmon of 'Conversations Life Science Leaders Aren't Having' and @russopartners, shedding light on effective collaboration with investors. #Biotech #Innovation #JPM2024 #Genomics
Russo Partners@russopartners
8 Jan 2024
Watch Mark McDonough, CEO of @chromacodeinc on 'Conversations Life Science Leaders Aren't Having' discuss investor confidence in #BioTech at #JPM2024. Key insights on balancing tech innovation with smart finance. #HealthcareInnovation #MarketInsights #JPM24
3:39
2
63
Load more